Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.
- NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_assertion description "[Short-term (30 min) pretreatment with forskolin (FSK; 10 muM), a direct activator of adenylyl cyclase, in combination with the cyclic nucleotide phosphodiesterase inhibitor isobutylmethylxanthine (IBMX; 200 muM), attenuated CCE in PASMC from normal subjects, patients without pulmonary hypertension (NPH), and patients with IPAH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.
- NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_assertion evidence source_evidence_literature NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.
- NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_assertion SIO_000772 17189322 NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.
- NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_assertion wasDerivedFrom befree-20150227 NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.
- NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_assertion wasGeneratedBy ECO_0000203 NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP612974.RAimE4yJl6u9T_AcbiDJ7o5C68wnwmjZP0m088g5OoRzA130_provenance.